STOCK TITAN

Qiming funds (ALMR) convert preferred stakes into common stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Alamar Biosciences, Inc. reported that investment vehicles affiliated with Qiming converted multiple series of preferred stock into equity tied to its initial public offering. Qiming-related funds converted Series A-3, Series A-4, Series B and Series C preferred stock into Class B Common Stock, and each Class B share was then automatically reclassified into Common Stock immediately before the IPO.

All transactions were indirect, recorded at a price of $0.00 per share, and coded as conversions or other internal restructurings rather than market purchases or sales. The Qiming general partner entities may be deemed to share voting and dispositive power but disclaim beneficial ownership beyond their proportionate economic interest.

Positive

  • None.

Negative

  • None.
Insider Qiming Corporate GP VI, Ltd., Qiming Managing Directors Fund VI, L.P., Qiming Venture Partners VI, L.P., Qiming GP VIII, LLC, Qiming Venture Partners VIII Investments, LLC, Qiming GP VIII-HC, LLC, Qiming Venture Partners VIII-HC, L.P.
Role null | null | null | null | null | null | null
Type Security Shares Price Value
Conversion Series A-3 Preferred Stock 172,328 $0.00 --
Conversion Series A-3 Preferred Stock 6,404,332 $0.00 --
Conversion Series A-4 Preferred Stock 154,425 $0.00 --
Conversion Series A-4 Preferred Stock 5,738,971 $0.00 --
Conversion Series B Preferred Stock 113,625 $0.00 --
Conversion Series B Preferred Stock 4,222,738 $0.00 --
Conversion Series C Preferred Stock 3,882,451 $0.00 --
Conversion Series C Preferred Stock 4,648,194 $0.00 --
Conversion Class B Common Stock 185,163 $0.00 --
Conversion Class B Common Stock 6,881,410 $0.00 --
Conversion Class B Common Stock 1,605,645 $0.00 --
Conversion Class B Common Stock 1,922,329 $0.00 --
Other Class B Common Stock 185,163 $0.00 --
Other Class B Common Stock 6,881,410 $0.00 --
Other Class B Common Stock 1,605,645 $0.00 --
Other Class B Common Stock 1,922,329 $0.00 --
Other Common Stock 185,163 $0.00 --
Other Common Stock 6,881,410 $0.00 --
Other Common Stock 1,605,645 $0.00 --
Other Common Stock 1,922,329 $0.00 --
Holdings After Transaction: Series A-3 Preferred Stock — 0 shares (Indirect, See footnote); Series A-4 Preferred Stock — 0 shares (Indirect, See footnote); Series B Preferred Stock — 0 shares (Indirect, See footnote); Series C Preferred Stock — 0 shares (Indirect, See footnote); Class B Common Stock — 185,163 shares (Indirect, See footnote); Common Stock — 185,163 shares (Indirect, See footnote)
Footnotes (1)
  1. Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date. These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock.
Derivative exercises 25,337,064 shares Preferred shares involved in derivative exercises and conversions
Restructuring entries 21,189,094 shares Shares in J-code internal restructuring transactions
Series C Preferred block 1 4,648,194 shares Converted into 1,922,329 shares of Class B Common Stock
Series C Preferred block 2 3,882,451 shares Converted into 1,605,645 shares of Class B Common Stock
Series B Preferred large block 4,222,738 shares Converted into 1,859,366 shares of Class B Common Stock
Series A-4 Preferred large block 5,738,971 shares Converted into 2,373,437 shares of Class B Common Stock
Series A-3 Preferred large block 6,404,332 shares Converted into 2,648,607 shares of Class B Common Stock
Common Stock indirect holding 6,881,410 shares One reported indirect Common Stock position after restructuring
Class B Common Stock financial
"Each share of Class B Common Stock was automatically reclassified into one share of Common Stock"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
Series A-3 Preferred Stock financial
"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted"
Series A-4 Preferred Stock financial
"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted"
Series B Preferred Stock financial
"Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock"
Series B preferred stock is a type of ownership share issued by a company that offers certain advantages over common stock, such as priority in receiving dividends or assets if the company is sold or liquidated. It is typically issued after an initial round of funding, making it a way for investors to support a company's growth while gaining some protections and benefits. This stock matters to investors because it often provides a more secure investment position with potential for future growth.
Conversion of derivative security financial
"transaction_code_description": "Conversion of derivative security""
disclaims beneficial ownership financial
"Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Qiming Corporate GP VI, Ltd.

(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309

(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104

(City)(State)(Zip)

CAYMAN ISLANDS

(Country)
2. Issuer Name and Ticker or Trading Symbol
Alamar Biosciences, Inc. [ ALMR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class B Common Stock04/20/2026C185,163A(1)(2)185,163ISee footnote(3)
Class B Common Stock04/20/2026C6,881,410A(1)(2)6,881,410ISee footnote(4)
Class B Common Stock04/20/2026C1,605,645A(1)1,605,645ISee footnote(5)
Class B Common Stock04/20/2026C1,922,329A(1)1,922,329ISee footnote(6)
Class B Common Stock04/20/2026J(7)185,163D(7)0ISee footnote(3)
Class B Common Stock04/20/2026J(7)6,881,410D(7)0ISee footnote(4)
Class B Common Stock04/20/2026J(7)1,605,645D(7)0ISee footnote(5)
Class B Common Stock04/20/2026J(7)1,922,329D(7)0ISee footnote(6)
Common Stock04/20/2026J(7)185,163A(7)185,163ISee footnote(3)
Common Stock04/20/2026J(7)6,881,410A(7)6,881,410ISee footnote(4)
Common Stock04/20/2026J(7)1,605,645A(7)1,605,645ISee footnote(5)
Common Stock04/20/2026J(7)1,922,329A(7)1,922,329ISee footnote(6)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Series A-3 Preferred Stock(1)04/20/2026C172,328 (1) (1)Class B Common Stock71,268$00ISee footnote(3)
Series A-3 Preferred Stock(1)04/20/2026C6,404,332 (1) (1)Class B Common Stock2,648,607$00ISee footnote(4)
Series A-4 Preferred Stock(1)04/20/2026C154,425 (1) (1)Class B Common Stock63,864$00ISee footnote(3)
Series A-4 Preferred Stock(1)04/20/2026C5,738,971 (1) (1)Class B Common Stock2,373,437$00ISee footnote(4)
Series B Preferred Stock(2)04/20/2026C113,625 (2) (2)Class B Common Stock50,031$00ISee footnote(3)
Series B Preferred Stock(2)04/20/2026C4,222,738 (2) (2)Class B Common Stock1,859,366$00ISee footnote(4)
Series C Preferred Stock(1)04/20/2026C3,882,451 (1) (1)Class B Common Stock1,605,645$00ISee footnote(5)
Series C Preferred Stock(1)04/20/2026C4,648,194 (1) (1)Class B Common Stock1,922,329$00ISee footnote(6)
1. Name and Address of Reporting Person*
Qiming Corporate GP VI, Ltd.

(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309

(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104

(City)(State)(Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Qiming Managing Directors Fund VI, L.P.

(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309

(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104

(City)(State)(Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Qiming Venture Partners VI, L.P.

(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309

(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104

(City)(State)(Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Qiming GP VIII, LLC

(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309

(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104

(City)(State)(Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Qiming Venture Partners VIII Investments, LLC

(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309

(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104

(City)(State)(Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Qiming GP VIII-HC, LLC

(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309

(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104

(City)(State)(Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Qiming Venture Partners VIII-HC, L.P.

(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309

(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104

(City)(State)(Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
Explanation of Responses:
1. Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date.
2. Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date.
3. These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
4. These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
5. These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
6. These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
7. Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock.
Qiming GP VIII, LLC By: /s/ Ho Man LAM/Authorized Signatory04/22/2026
Qiming Venture Partners VIII Investments, LLC By: /s/ Ho Man LAM/Manager04/22/2026
Qiming Corporate GP VI, Ltd By: /s/ Ho Man LAM/Authorized Signatory04/22/2026
Qiming Managing Directors Fund VI, L.P. By: /s/ Ho Man LAM/Authorized Signatory04/22/2026
Qiming Venture Partners VI, L.P. By: /s/ Ho Man LAM/Authorized Signatory04/22/2026
Qiming GP VIII-HC, LLC By: /s/ Ho Man LAM/Authorized Signatory04/22/2026
Qiming Venture Partners VIII-HC, L.P. By: /s/ Ho Man LAM/Authorized Signatory04/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did the Qiming entities report in the Alamar Biosciences (ALMR) Form 4?

The Qiming-affiliated entities reported conversions of preferred stock into Class B and then Common Stock tied to Alamar Biosciences’ initial public offering. These were indirect, non-cash restructurings with no reported open-market purchases or sales, and were coded mainly as conversions of derivative securities.

Were there any open-market buys or sells in this Alamar Biosciences (ALMR) Form 4?

No open-market purchases or sales were reported. The transactions were coded as conversions (C) and other transactions (J), all at a reported price of $0.00 per share, indicating internal restructurings and derivative conversions rather than cash trades in the market.

Who actually holds the Alamar Biosciences (ALMR) shares linked to the Qiming entities?

The shares are held of record by specific Qiming funds and investment vehicles, such as Qiming Managing Directors Fund VI, L.P. and Qiming Venture Partners funds. General partner entities may share voting and dispositive power but disclaim beneficial ownership beyond their proportionate pecuniary interests.

What does the Form 4 say about Alamar Biosciences (ALMR) Class B Common Stock?

Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately before completion of Alamar Biosciences’ initial public offering. The Form 4 records this as indirect, non-cash transactions involving Qiming-affiliated investment entities.

How many Alamar Biosciences (ALMR) preferred shares were involved in the Qiming conversions?

The transaction summary reports 25,337,064 preferred shares involved in derivative exercises, converted into Class B Common Stock and then into Common Stock. These conversions reflect restructuring of Qiming-related holdings around Alamar Biosciences’ initial public offering rather than new capital inflows or disposals.